![](https://investorshub.advfn.com/uicon/757150.png?cb=1600125324)
Sunday, October 11, 2020 9:17:02 PM
From these tests results, the effectiveness of our recombinant antibody as compared to all other anti-HIV monoclonal antibodies thus far produced by pharma and the NIH, our recombinant tested at 2.6 times more effective than the best no. 1 antibody – VRC01 – and 6 times more effective than the no. 2 next best anti-HIV monoclonal antibody – VRC01 – (both produced by Vaccine Research Center
$enzc
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM